Skip to Content

Tools

Report

PEPFAR Implementation: Progress and Promise

Released:
March 30, 2007
Type:
Consensus Report
Topic(s):
Biomedical and Health Research, Diseases, Global Health
Activity:
President's Emergency Plan for AIDS Relief [PEPFAR] Implementation Evaluation
Board(s):
Board on Global Health

In 2003 Congress passed the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which established a five-year, $15 billion initiative to help countries around the world respond to their AIDS epidemics. The initiative is generally referred to by the title of the five-year strategy required by the act—PEPFAR, or the President’s Emergency Plan for AIDS Relief.

A requirement of the act which established PEPFAR was that the Institute of Medicine (IOM) provide Congress with an evaluation of the initiative’s progress three years after the passage of the Leadership Act. In response, the IOM Committee for the Evaluation of PEPFAR Implementation examined the initiative, including visits to most of the fifteen PEPFAR focus countries.

Overall, the Committee concludes that PEPFAR has made a promising start, but it warns that there is an enduring need for U.S. leadership in the effort to respond to the HIV/AIDS pandemic. To that end, the Committee has made a number of recommendations, including the following:

  • A transition from its focus on emergency relief to an emphasis on long-term strategic planning and capacity building for a sustainable response.
  • Addressing the long term factors that underlie the epidemics in each country including:
  • Emphasizing and enhancing prevention with accumulation of better data to determine the most appropriate interventions needed in the countries.
  • Empowering women and girls by increasing focus on the factors that put them at greater risk of HIV/AIDS, and to support improvements in their legal, economic, educational, and social status.
  • Building workforce capacity by increasing its support and including the education of new health care workers in addition to AIDS-related training for existing health care workers.
  • Expanding the knowledge base by emphasizing evidence-based approaches, learning from experience, and adaptation to new developments; as well as conducting operations research and robust program monitoring and evaluation.
  • Improving Harmonization by improving coordination with partner governments and other donors and supporting the WHO Prequalification Process for medications obtained through PEPFAR.  In addition, the Committee recommends that Congress remove the budgetary allocations but replace them with alternative mechanisms for accountability to ensure results and to permit Country Teams the maximum flexibility to achieve the 5-year performance targets for supporting prevention of 7 million infection, providing antiretroviral therapy to 2 million people, and care for 10 million people affected by HIV/AIDS including orphans and vulnerable children.
  • Expanding, improving, and integrating prevention, treatment, care, and orphan and vulnerable children services; and increasing attention to marginalized populations including commercial sex workers, people who use injecting drugs, prisoner, and men who have sex with men.

Report at a Glance

Report Brief (PDF)

Other Reports by this Activity

  • Design Considerations for Evaluating the Impact of PEPFAR. Workshop Summary Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President’s Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007.
    Released: September 15, 2008
  • Plan for a Short-Term Evaluation of PEPFAR Implementation: Letter Report 1 Concern for the over 40 million people infected with HIV and others at risk of infection or otherwise affected through the impact on their families and communities moved the US Congress on behalf of the American people to pass in May 2003 an unprecedented $15 billion international public health initiative--the US Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act. Congress mandated that the Institute of Medicine review the groundbreaking initiative created by the legislation--the President's Emergency Plan for AIDS Relief (PEPFAR).
    Released: October 31, 2005

Previous Meeting for this Activity

Get this Report

Stay up to date!